Clinical TrialsSearch results
Number of results: 320
Recruiting
- Phase II study of ramucirumab for the patients with advanced hepatocellular carcinoma previously treated with lenvatinib
- Hepatocellular carcinoma
- Yamashita Tatsuya
- 2019-11-21
Recruiting
- Phase II study of sorafenib-regorafneib sequential therapy for the patients with advanced hepatocellular carcinoma previously treated with lenvatinib
- Hepatocellular carcinoma
- Yamashita Tatsuya
- 2019-11-21
Recruiting
- Preceding local therapy to STRIDE for pretreated patients
- Hepatocellular carcinoma
- Yamashita Tatsuya
- 2023-04-22
Recruiting
- preceding RFA to Atezo+Bev for HCC patients
- hepatocellular carcinoma
- Yamashita Tatsuya
- 2020-12-15
Recruiting
- Preceding RFA to STRIDE trial
- Hepatocellular carcinoma
- Yamashita Taro
- 2024-06-18
Other
- Atezo+Bev study for pretreated patients
- hepatocellular carcinoma
- Yamashita Tatsuya
- 2020-11-25
Other
- Expanded Treatment Efficacy and Safety Study of Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Epirubicin/ Doxorubicin-Lipiodol Emulsion and Gelatin Particles: Korea-Japan Cooperative Study (JIVROSG-0604)
- hepatocellular carcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-01-08
Other
- Phase-I/IIa study of radiofrequency ablation combined with in situ application of immune adjuvant for hepatocellular carcinoma
- Hepatocellular carcinoma
- Kanazawa university
- 2008-07-01
Other
- Phase-I/IIa study of radiofrequency ablation combined with in situ application of immunoadjuvant, Cal-TUMP
- Hepatocellular carcinoma
- Kanazawa university
- 2010-04-01
Other
- Cohort study to investigate the clinical factors associated with the prognosis of high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17